North America Clinical Laboratory Services Market - Industry Trends and Forecast To 2027

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.10 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING INFECTIOUS DISEASES WORLDWIDE

3.1.2 ADVANCEMENT IN CLINICAL DIAGNOSTIC METHODS

3.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS

3.1.4 RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS

3.1.5 GROWING APPLICATION OF HIGH-THROUGHPUT ASSAYS

3.2 RESTRAINTS

3.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS

3.2.2 STRICT REGULATORY POLICIES

3.3 OPPORTUNITIES

3.3.1 GROWING ADOPTION OF DIGITAL PATHOLOGY PLATFORMS

3.3.2 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS

3.3.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE

3.3.4 STRATEGIC INITIATIVES BY MARKET PLAYERS

3.4 CHALLENGES

3.4.1 INACCURATE RESULTS OF TESTS

3.4.2 INADEQUATE REIMBURSEMENTS POLICIES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY

6.1 OVERVIEW

6.2 CLINICAL CHEMISTRY TESTING

6.2.1 ROUTINE CHEMISTRY TESTING

6.2.2 THERAPEUTIC DRUG MONITORING (TDM) TESTING

6.2.3 ENDOCRINOLOGY CHEMISTRY TESTING

6.2.4 SPECIALIZED CHEMISTRY TESTING

6.2.5 OTHER CLINICAL CHEMISTRY TESTING

6.3 HEMATOLOGY TESTING

6.3.1 ROUTINE HEMATOLOGY TESTING

6.3.2 SPECIALIZED HEMATOLOGY TESTING

6.3.3 COAGULATION TESTING

6.4 MICROBIOLOGY TESTING

6.4.1 INFECTIOUS DISEASE TESTING

6.4.2 TRANSPLANT DIAGNOSTIC TESTING

6.4.3 OTHER MICROBIOLOGY TESTING

6.5 IMMUNOLOGY TESTING

6.6 DRUGS OF ABUSE TESTING

6.7 CYTOLOGY TESTING

6.8 GENETIC TESTING

7 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER

7.1 OVERVIEW

7.2 HOSPITAL-BASED LABORATORIES

7.3 INDEPENDENT & REFERENCE LABORATORIES

7.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES

8 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 BIOANALYTICAL & LAB CHEMISTRY SERVICES

8.3 DRUG DEVELOPMENT RELATED SERVICES

8.4 DRUG DISCOVERY RELATED SERVICES

8.5 TOXICOLOGY TESTING SERVICES

8.6 CELL & GENE THERAPY RELATED SERVICES

8.7 PRECLINICAL & CLINICAL TRIAL RELATED SERVICES

8.8 OTHER CLINICAL LABORATORY SERVICES

9 CLINICAL LABORATORY SERVICES MARKET, BY GEOGRAPHY

9.1 NORTH AMERICA

9.1.1 U.S.

9.1.2 CANADA

9.1.3 MEXICO

10 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

11 COMPANY PROFILE

11.1 SIEMENS HEALTHINEERS AG

11.1.1 COMPANY SNAPSHOT

11.1.1 REVENUE ANALYSIS

11.1.2 COMPANY SHARE ANALYSIS

11.1.3 SERVICE PORTFOLIO

11.1.4 RECENT DEVELOPMENT

11.2 SPECTRA LABORATORIES (A SUBSIDIARY OF FRESENIUS MEDICAL CARE AG & CO. KGAA)

11.2.1 COMPANY SNAPSHOT

11.2.2 REVENUE ANALYSIS

11.2.3 COMPANY SHARE ANALYSIS

11.2.4 SERVICE PORTFOLIO

11.2.5 RECENT DEVELOPMENT

11.3 DAVITA INC.

11.3.1 COMPANY SNAPSHOT

11.3.2 REVENUE ANALYSIS

11.3.3 COMPANY SHARE ANALYSIS

11.3.4 SERVICE PORTFOLIO

11.3.5 RECENT DEVELOPMENT

11.4 LABORATORY CORPORATION OF AMERICA

11.4.1 COMPANY SNAPSHOT

11.4.2 REVENUE ANALYSIS

11.4.3 COMPANY SHARE ANALYSIS

11.4.4 SERVICE PORTFOLIO

11.4.5 RECENT DEVELOPMENT

11.5 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH

11.5.1 COMPANY SNAPSHOT

11.5.2 SERVICE PORTFOLIO

11.5.3 RECENT DEVELOPMENT

11.6 QUEST DIAGNOSTICS INCORPORATED

11.6.1 COMPANY SNAPSHOT

11.6.2 REVENUE ANALYSIS

11.6.3 COMPANY SHARE ANALYSIS

11.6.4 SERVICE PORTFOLIO

11.6.5 RECENT DEVELOPMENTS

11.7 SONIC HEALTHCARE

11.7.1 COMPANY SNAPSHOT

11.7.2 REVENUE ANALYSIS

11.7.3 SERVICE PORTFOLIO

11.7.4 RECENT DEVELOPMENTS

11.8 SYNLAB INTERNATIONAL GMBH

11.8.1 COMPANY SNAPSHOT

11.8.2 SERVICE PORTFOLIO

11.8.3 RECENT DEVELOPMENTS

11.9 ABBOTT

11.9.1 COMPANY SNAPSHOT

11.9.2 REVENUE ANALYSIS

11.9.3 PRODUCT PORTFOLIO

11.9.4 RECENT DEVELOPMENT

11.10 CHARLES RIVER

11.10.1 COMPANY SNAPSHOT

11.10.2 REVENUE ANALYSIS

11.10.3 SERVICE PORTFOLIO

11.10.4 RECENT DEVELOPMENT

11.11 KINGMED DIAGNOSTICS

11.11.1 COMPANY SNAPSHOT

11.11.2 SERVICE PORTFOLIO

11.11.3 RECENT DEVELOPMENTS

11.12 ACM NORTH AMERICA LABORATORIES

11.12.1 COMPANY SNAPSHOT

11.12.2 SERVICE PORTFOLIO

11.12.3 RECENT DEVELOPMENTS

11.13 AMEDES HOLDING GMBH

11.13.1 COMPANY SNAPSHOT

11.13.2 SERVICE PORTFOLIO

11.13.3 RECENT DEVELOPMENT

11.14 BIOREFERENCE LABORATORIES, INC. (A SUBSIDIARY OF OPKO HEALTH, INC.)

11.14.1 COMPANY SNAPSHOT

11.14.2 REVENUE ANALYSIS

11.14.3 SERVICE PORTFOLIO

11.14.4 RECENT DEVELOPMENT

11.15 EUROFINS SCIENTIFIC

11.15.1 COMPANY SNAPSHOT

11.15.2 REVENUE ANALYSIS

11.15.3 SERVICE PORTFOLIO

11.15.4 RECENT DEVELOPMENT

11.16 GENOMIC HEALTH

11.16.1 COMPANY SNAPSHOT

11.16.2 REVENUE ANALYSIS

11.16.3 PRODUCT PORTFOLIO

11.16.4 RECENT DEVELOPMENT

11.17 LIFELABS

11.17.1 COMPANY SNAPSHOT

11.17.2 SERVICE PORTFOLIO

11.17.3 RECENT DEVELOPMENTS

11.18 MIRACA HOLDINGS INC.

11.18.1 COMPANY SNAPSHOT

11.18.2 REVENUE ANALYSIS

11.18.3 SERVICE PORTFOLIO

11.18.4 RECENT DEVELOPMENT

11.19 NEOGENOMICS LABORATORIES, INC

11.19.1 COMPANY SNAPSHOT

11.19.2 REVENUE ANALYSIS

11.19.3 SERVICE PORTFOLIO

11.19.4 RECENT DEVELOPMENTS

11.20 UNILABS

11.20.1 COMPANY SNAPSHOT

11.20.2 SERVICE PORTFOLIO

11.20.3 RECENT DEVELOPMENTS

12 QUESTIONNAIRE

13 RELATED REPORTS

TABLE 1 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 2 NORTH AMERICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 3 NORTH AMERICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 4 NORTH AMERICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 NORTH AMERICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 6 NORTH AMERICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 7 NORTH AMERICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 8 NORTH AMERICA IMMUNOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 NORTH AMERICA DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 NORTH AMERICA CYTOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 NORTH AMERICA GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2018-2027 (USD MILLION)

TABLE 13 NORTH AMERICA HOSPITAL-BASED LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 NORTH AMERICA INDEPENDENT & REFERENCE LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 NORTH AMERICA NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 17 NORTH AMERICA BIOANALYTICAL & LAB CHEMISTRY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 NORTH AMERICA DRUG DEVELOPMENT RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 NORTH AMERICA DRUG DISCOVERY RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 NORTH AMERICA TOXICOLOGY TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 21 NORTH AMERICA CELL & GENE THERAPY RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 NORTH AMERICA PRECLINICAL & CLINICAL TRIAL RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 NORTH AMERICA OTHER CLINICAL LABORATORY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 25 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 26 NORTH AMERICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 27 NORTH AMERICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 28 NORTH AMERICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 29 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2018-2027 (USD MILLION)

TABLE 30 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 31 U.S. CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 32 U.S. CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 33 U.S. MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 34 U.S. HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 35 U.S. CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2018-2027 (USD MILLION)

TABLE 36 U.S. CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 37 CANADA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 38 CANADA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 39 CANADA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 40 CANADA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 41 CANADA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2018-2027 (USD MILLION)

TABLE 42 CANADA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 43 MEXICO CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 44 MEXICO CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 45 MEXICO MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 46 MEXICO HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2018-2027 (USD MILLION)

TABLE 47 MEXICO CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2018-2027 (USD MILLION)

TABLE 48 MEXICO CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)